Investment
Features
FeesSafety
Academy
More
Pluang+

Compare HCA Health Inc (HCA) vs Vanguard High Dividend Yield ETF (VYM) Price & Performance

HCA Health IncTrade
Vanguard High Dividend Yield ETFTrade

Price performance (Past 24H)

Key statistics

HCA Health Inc vs Vanguard High Dividend Yield ETF — how do they compare? HCA Health Inc trades at $443.69 (market cap $95.08B), while Vanguard High Dividend Yield ETF trades at $158.5 (market cap $100.80B). The key difference: HCA Health Inc and Vanguard High Dividend Yield ETF are close in size by market cap, and HCA Health Inc pays a 0.71% dividend while Vanguard High Dividend Yield ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold HCA Health Inc for 76 Days and Vanguard High Dividend Yield ETF for 138 Days on average.

HCAVYM
Market Cap
$95.08B$100.80B
Volume
998,787993,696
Sector
Health—
52-Week High
$545.13$167.03
52-Week Low
$361.32$137.47
Typical Hold Time
76 Days138 Days
Enterprise Value
$145.62B—
Dividend Yield
0.71%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

HCA Health Inc

HCA Healthcare (HCA) trades at $445.01, up 2.96% today, with a bullish technical signal and strong earnings beats in recent quarters. Revenue grew to $75.6B in 2025, with net income of $6.78B, and the stock trades at a P/E of 14.73. Analyst consensus is a Buy with a $461.12 price target, though ongoing legal investigations pose a headwind.

The outlook remains positive given solid demand and cost controls, but risks include payer-mix pressure and high debt levels. Upside potential exists if earnings growth continues, but investors should monitor legal developments and interest rate impacts on the leveraged balance sheet.

Vanguard High Dividend Yield ETF

VYM trades at $157.45, down 0.58% on the day, with a bearish technical signal from moving averages while oscillators remain neutral. The ETF's 2.42% yield provides consistent income, though recent articles highlight performance comparisons with peers like SCHD and IDV. Support and resistance levels cluster tightly around $157-158, indicating potential for near-term price consolidation.

The outlook remains cautious as VYM faces competitive pressure from higher-yielding alternatives and concerns about dividend sustainability in its holdings. While diversification and low costs are strengths, investors should weigh the trade-offs between yield consistency and total return potential in the current market environment.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

HCA
100% Buy0% Sell
Avg holding period · 76 Days
VYM
32% Buy68% Sell
Avg holding period · 138 Days

Top news

Latest headlines on both assets

About HCA Health Inc

HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.

Read more on HCA →

About Vanguard High Dividend Yield ETF

The advisor employs an indexing investment approach designed to track the performance of the index, which consists of common stocks of companies that pay dividends that generally are higher than average. The advisor attempts to replicate the target index by investing all, or substantially all, of the fund's assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index.

Read more on VYM →